T-STAT Drug Patent Profile
✉ Email this page to a colleague
When do T-stat patents expire, and what generic alternatives are available?
T-stat is a drug marketed by Westwood Squibb and is included in two NDAs.
The generic ingredient in T-STAT is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for T-stat
A generic version of T-STAT was approved as erythromycin by TORRENT on July 6th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for T-STAT?
- What are the global sales for T-STAT?
- What is Average Wholesale Price for T-STAT?
Summary for T-STAT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Patent Applications: | 4,166 |
| DailyMed Link: | T-STAT at DailyMed |
US Patents and Regulatory Information for T-STAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Westwood Squibb | T-STAT | erythromycin | SOLUTION;TOPICAL | 062436-001 | Mar 9, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Westwood Squibb | T-STAT | erythromycin | SWAB;TOPICAL | 062748-001 | Jul 23, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
